Viewing Study NCT00597493

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-22 @ 8:54 PM
Study NCT ID: NCT00597493
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2008-01-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent Glioblastoma Multiforme View
None GBM View
None Glioblastoma View
None Sorafenib View
None Temozolomide View
None Brain Tumor View
None Recurrent GBM View
None Temodar View
None Gliosarcoma View
None Glioma View
None Nexavar View